Varicose Veins Treatment Market Analysis

Product (Ablation Devices, Sclerotherapy Injections)

The ablation devices segment is estimated to dominate 60% of the global varicose veins treatment market share by 2037, attributed to the increasing adoption of laser ablation technology in the treatment pathway. The increased convenience and ease in the use of ablation devices are poised to contribute to the growth of the segment. A research study demonstrated that laser ablating therapy was cost-effective and the preferred first treatment for asymptomatic varicose veins which had a diameter of not less than 3 mm.

Procedure (Injection Sclerotherapy, Endovenous Ablation, Surgical Ligation)

Varicose veins treatment market from the injection sclerotherapy segment is set to grow at a significant CAGR till 2037. The benefits of this treatment, including less bruising and scars, absence of anesthesia, shortened hospital stays, and simpler follow-up procedures are the main reasons why it is dominating the market share. In addition, patients who are receiving injections of sclerotherapy in the U.S. can be covered by Medicare. A number of organizations set up campaigns in support of the awareness and use of different treatments every year.

Our in-depth analysis of the global market includes the following segments: